Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
79.20    -0.85 (-1.06%)
Bid:
79.20
Ask:
79.50
Spread: 0.30 (0.379%)
Market Cap: £1.52b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Director/PDMR Shareholding

4 Mar 2022 14:51

RNS Number : 7373D
Coats Group PLC
04 March 2022
 

4 March 2022

Coats Group plc

Director/PDMR Shareholding

 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and their Closely Associated Persons

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jacqueline Callaway 

b)

Position/status

Chief Financial Officer

c)

Initial notification/ Amendment

Initial notification 

2

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of entity

Coats Group plc

b)

Legal Entity Identifier Code

2138003SPYWGAITNFY17

3

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Share award constituting a right to acquire Ordinary shares of £0.05

 

b)

Identification code/ ISIN

GB00B4YZN328

c)

Nature of the transaction

Award of nil cost share options under the terms of the Coats Group plc Long Term Incentive Plan ("LTIP") and Deferred Annual Bonus Plan ("DABP") as set out at 1 and 2 respectively below:

1. The LTIP award vests on 4 March 2025 subject to the satisfaction of performance conditions measured over a three year performance period commencing on 1 January 2022 relating to compound annual growth in realised earnings per share in 2024, total shareholder return, cumulative free cash flow and sustainability objectives; and

 

2. The DABP awards represent a proportion of the annual bonus awarded for the year ended 31 December 2021 and vest after 3 years from the date of the award. DABP awards are not subject to performance conditions, as the bonus targets in respect of 2021 have already been met, but awards are subject to certain forfeiture and clawback provisions in certain situations such as personal misconduct or a misstatement of results.

d)

Price(s) and volume(s)

Price(s)

Volume(s)

1. Nil

 

2. Nil

1. 904,157

 

2. 258,709

e)

Aggregated information- Aggregated volume- Price

 

1,162,866

n/a

f)

Date of the transaction

4 March 2022 

 

g)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

 

 

Enquiry details

 

 

 

 

Investors

Victoria Huxster

Coats Group plc

+44 (0)7880 471350

 

Nick Kidd

Coats Group plc

+44 (0)7770 735719

 

Media

 

Richard Mountain / Nick Hasell

 

FTI Consulting

 

+44 (0)20 3727 1374

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUSVSRURUORAR
Date   Source Headline
31st Jan 202011:10 amRNSTotal Voting Rights
8th Jan 20202:35 pmRNSBlock listing Interim Review
2nd Jan 202011:42 amRNSTotal Voting Rights
3rd Dec 201911:33 amRNSDirector/PDMR Shareholding
26th Nov 20197:00 amRNSAcquisition
22nd Nov 20197:00 amRNSTrading Statement
1st Nov 20199:13 amRNSDirector Declaration
24th Oct 20198:21 amRNSHolding(s) in Company
4th Oct 201912:40 pmRNSBlock listing Interim Review
30th Sep 20192:48 pmRNSTotal Voting Rights
27th Sep 20192:20 pmRNSHolding(s) in Company
19th Sep 20194:31 pmRNSHolding(s) in Company
30th Aug 201910:29 amRNSTotal Voting Rights
1st Aug 20197:00 amRNSHalf-year Report
31st Jul 20192:49 pmRNSTotal Voting Rights
9th Jul 20191:40 pmRNSBlock listing Interim Review
28th Jun 20192:36 pmRNSTotal Voting Rights
31st May 20193:37 pmRNSTotal Voting Rights
23rd May 20196:16 pmRNSResult of AGM
23rd May 20197:00 amRNSTrading Update
30th Apr 201911:56 amRNSTotal Voting Rights
24th Apr 201911:55 amRNSAGM Statement
5th Apr 201912:15 pmRNSBlock listing Interim Review
2nd Apr 20191:58 pmRNSTotal Voting Rights
8th Mar 201911:28 amRNSAnnual Financial Report 2018
4th Mar 20192:25 pmRNSDirector/PDMR Shareholding
4th Mar 20192:23 pmRNSDirector/PDMR Shareholding
1st Mar 20197:00 amRNS2018 Full Year Results
28th Feb 20192:59 pmRNSTotal Voting Rights
27th Feb 20191:42 pmRNSAdditional Listing
22nd Jan 20197:00 amRNSSale of North America Crafts
17th Jan 20191:48 pmRNSBlock listing Interim Review
8th Jan 20194:08 pmRNSBlock listing Interim Review
2nd Jan 201911:48 amRNSTotal Voting Rights
20th Dec 20187:00 amRNSAcquisition of ThreadSol
19th Dec 20182:39 pmRNSHolding(s) in Company
19th Dec 20187:00 amRNSAppointment of Joint Corporate Broker
4th Dec 20187:00 amRNSStrategic investment
30th Nov 201812:52 pmRNSTotal Voting Rights
20th Nov 20187:00 amRNSTrading Update
31st Oct 20181:03 pmRNSTotal Voting Rights
9th Oct 20187:01 amRNSDirector Declaration
28th Sep 20182:21 pmRNSTotal Voting Rights
31st Aug 201811:22 amRNSTotal Voting Rights
30th Aug 201811:21 amRNSHolding(s) in Company
6th Aug 201812:57 pmRNSHolding(s) in Company
31st Jul 201811:11 amRNSTotal Voting Rights
31st Jul 20187:00 amRNSHalf-year Report
6th Jul 201812:04 pmRNSBlock listing Interim Review
29th Jun 201811:07 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.